Nearly a dozen pharmaceutical companies launched programs to develop drugs or vaccines against the new virus, 2019-nCoV, which belongs to the coronavirus family. Immunizing people against infections is the best way to prevent spread of disease and protect entire populations. Members of the infectious-disease team at US National Institute of Health (NIH) immediately went to work on their vaccine. They alerted researchers at Moderna Therapeutics, based in Cambridge, Mass., to be ready in three months to manufacture the first promising candidate for testing and, if the vaccine proved safe and effective, to ramp up production for however many doses would be needed to protect the public. The work is being funded by the recently formed Coalition for Epidemic Preparedness Innovation, a group of public and private organizations dedicated to speeding development of new vaccines.
https://www.sumeetsud.com/sumeet-sud-shares-news-of-the-race-for-a-vaccine-against-virus/
https://www.sumeetsud.com/tag/coronavirus/
https://www.sumeetsud.com/tag/nih/
https://www.sumeetsud.com/tag/vaccine/